WALTHAM, Mass., Feb. 17, /PRNewswire/ — Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe Alzheimer’s disease, a combination therapy that delays nursing home admission at 19 months
Popularity: unranked [?]

